Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-02 Sale | 2024-08-05 4:37 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 5,220 | $9.0161 | $47,064 | 183,288 (Direct) | View |
| 2024-05-28 Sale | 2024-05-29 7:38 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,775 | $9.0074 | $15,988 | 188,508 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 4:22 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 5,016 | $8.7378 | $43,829 | 185,408 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 5:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 3,760 | $11.12 | $41,816 | 190,424 (Direct) | View |
| 2023-11-21 Sale | 2023-11-21 5:47 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,850 | $1.979 | $3,661 | 46,634 (Direct) | View |
| 2023-05-31 Sale | 2023-06-02 8:31 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,830 | $7.8023 | $14,278 | 43,609 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:52 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 1,434 | $15.83 | $22,696 | 94,901 (Direct) | View |
| 2022-11-21 Sale | 2022-11-22 7:06 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,720 | $18.19 | $31,289 | 19,535 (Direct) | View |
| 2022-06-02 Sale | 2022-06-02 4:48 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel | 1,795 | $19.73 | $35,419 | 16,380 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-27 Option Award | 2024-05-29 7:38 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 188,508 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:32 pm | N/A 2032-01-03 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 276,100 | $0 | 194,184 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:32 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 119,550 | $0 | 194,184 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:32 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 204,000 | $0 | 250,634 (Direct) | View |
| 2023-11-18 Option Award | 2023-11-21 5:47 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 46,634 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:31 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,463 | $6.38 | 43,609 (Direct) | View |
| 2023-05-27 Option Award | 2023-06-02 8:31 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 43,609 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:52 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 76,800 | $0 | 94,901 (Direct) | View |
| 2022-11-18 Option Award | 2022-11-22 7:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 19,535 (Direct) | View |
| 2022-05-27 Option Award | 2022-06-02 4:48 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel | 4,875 | $0 | 16,380 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:52 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel | 48,600 | $0 | 48,600 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:43 pm | N/A 2032-01-03 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel | 185,000 | $0 | 185,000 (Direct) | View |
| 2021-09-04 Exercise | 2021-09-07 5:42 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 6,883 | $0 | 26,932 (Direct) | View |
| 2021-09-04 Tax Withholding | 2021-09-07 5:42 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 3,412 | $42.22 | 26,932 (Direct) | View |
| 2021-02-15 Option Award | 2021-02-17 5:05 pm | 2022-02-15 2031-02-15 | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 36,855 | $0 | 36,855 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 7:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 10,386 | $0 | 43,605 (Direct) | View |
| 2021-02-12 Tax Withholding | 2021-02-12 7:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 2,047 | $49.84 | 43,605 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-12 7:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 3,203 | $50.6 | 43,605 (Direct) | View |
| 2020-09-04 Exercise | 2020-09-04 6:13 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 6,884 | $0 | 25,208 (Direct) | View |
| 2020-09-04 Tax Withholding | 2020-09-04 6:13 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 2,380 | $27.7 | 25,208 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-13 6:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 4,130 | $0 | 19,325 (Direct) | View |
| 2020-02-12 Tax Withholding | 2020-02-13 6:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 1,681 | $20 | 19,325 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:05 pm | 2021-02-10 2030-02-10 | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 78,237 | $0 | 78,237 (Direct) | View |
Ownership | 2020-01-06 4:29 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel | 0 | $0 | 175,136 (Direct) | View |